Rhinomed Limited, a medical device company based in Australia, focuses on developing and commercializing nasal stent technologies for various applications such as improved breathing for sports, anti-snoring, vapor inhalation for better sleep, and diagnostic purposes. In addition, the company is involved in developing programs related to sleep, respiratory function, pain, nausea, and diagnostic sensors. The company recently changed its name from Consegna Group Limited to Rhinomed Limited in 2013.